| 000 | 01760 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517002659.0 | ||
| 264 | 0 | _c20151019 | |
| 008 | 201510s 0 0 eng d | ||
| 022 | _a1999-4915 | ||
| 024 | 7 |
_a10.3390/v6114358 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGörander, Staffan | |
| 245 | 0 | 0 |
_aAnti-glycoprotein g antibodies of herpes simplex virus 2 contribute to complete protection after vaccination in mice and induce antibody-dependent cellular cytotoxicity and complement-mediated cytolysis. _h[electronic resource] |
| 260 |
_bViruses _cNov 2014 |
||
| 300 |
_a4358-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Viral _xblood |
| 650 | 0 | 4 | _aAntibody-Dependent Cell Cytotoxicity |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 | _aComplement System Proteins |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHerpes Simplex _ximmunology |
| 650 | 0 | 4 |
_aHerpes Simplex Virus Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aHerpesvirus 2, Human _ximmunology |
| 650 | 0 | 4 | _aImmunization, Passive |
| 650 | 0 | 4 |
_aImmunoglobulin G _xblood |
| 650 | 0 | 4 | _aInjections, Intramuscular |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 |
_aInterferon-gamma _xmetabolism |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aViral Envelope Proteins _ximmunology |
| 700 | 1 | _aEkblad, Maria | |
| 700 | 1 | _aBergström, Tomas | |
| 700 | 1 | _aLiljeqvist, Jan-Åke | |
| 773 | 0 |
_tViruses _gvol. 6 _gno. 11 _gp. 4358-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3390/v6114358 _zAvailable from publisher's website |
| 999 |
_c24354798 _d24354798 |
||